EGCG for Hepatocellular Carcinoma Chemoprevention

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

August 31, 2028

Study Completion Date

August 31, 2028

Conditions

Cirrhosis, Liver

Interventions

DRUG

Epigallocatechin gallate (EGCG)

EGCG is a green tea-derived catechin

OTHER

Placebo

Placebo in the same capsule with the experimental agent (EGCG).

Trial Locations (1)

RECRUITING

UT Southwestern, Dallas

All Listed Sponsors

lead

University of Texas Southwestern Medical Center

OTHER